Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. Hepcinat Ip (Gilead Sciences, Inc.) is a prescription care which contains a combination of Hepcinat and Ledipasvir in the dosages form of 90mg and 400 mg that is used for treatment of Chronic Hepatitis C (CHC) genotype 1 infection in adults. It is not recognized yet if Hepcinat Ip is safe and effective care for children under 18 years of age.
Genotype 1 HCV is the most common infection accounting for 70 to 75% of the entirely Hepatitis C infections in the UNITED STATES. Ledipasvir and Hepcinat are antiviral medications that help to prevent hepatitis C virus (HCV) cells from multiplying in your body.
The Indian generic of Hepcinat Ip to be manufactured by NATCO PHARMA LIMITED will soon be available in INDIA under the trade name HEPCINAT-LP. This drug will also have similar effects as Hepcinat Ip in treating Chronic Hepatitis C (CHC) genotype 1 infection in adults. The recommended dosage of Hepcinat-LP is one tablet taken orally once daily with or without food.
Please share your contact details and we will get in touch with you soon.
NOTE : Hepcinat-LP is a prescription drug and should be used under proper medical guidance and advice.